Trinatal Ultra description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Trinatal Ultra

TRIGEN Laboratories, Inc.

Trinatal Ultra Tablets


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Rx Only

TRINATAL ULTRA DESCRIPTION

Trinatal Ultra is a prescription prenatal multivitamin/multimineral tablet which contains calcium citrate and carbonyl iron. Each dye-free, oil-and-water soluble, white tablet is debossed "TL615".

Supplement Facts
Servings per Bottle: 100
Serving Size: 1 Tablet
Each Tablet contains
%DV for Pregnant and
Lactating Women
Vitamin A (vitamin A palmitate and beta carotene) 2700 IUInput as Vitamin A palmitate and beta carotene. 34%
Vitamin C (ascorbic acid) 120 mg 200%
Vitamin D3 (cholecalciferol) 400 IU 100%
Vitamin E (dl-alpha-tocopheryl acetate) 30 IU 100%
Vitamin B1 (thiamine mononitrate) 3 mg 176%
Vitamin B2 (riboflavin) 3.4 mg 170%
Niacinamide 20 mg 100%
Vitamin B6 (pyridoxine HCl) 20 mg 800%
Folic Acid 1 mg 125%
Vitamin B12 (cyanocobalamin) 12 mcg 150%
Calcium (calcium citrate) 200 mg 15%
Iron, Elemental (carbonyl iron) 90 mg 500%
Iodine (potassium iodide) 150 mcg 100%
Zinc (zinc oxide) 25 mg 167%
Copper (cupric oxide) 2 mg 100%
Docusate Sodium 50 mg 3%

Inactive Ingredients

Microcrystalline Cellulose, TriPotassium Citrate, Croscarmellose Sodium, Magnesium Stearate, Acacia, Citric Acid, Povidone K30, Fumed Silica, Stearic Acid, Hypromellose, Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol, Talc.

TRINATAL ULTRA INDICATIONS AND USAGE

Trinatal Ultra is a multivitamin/multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. Trinatal Ultra can also be beneficial in improving the nutritional status of women prior to conception.

TRINATAL ULTRA CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNINGS

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

General

The calcium content should be considered before prescribing for patients with kidney stones. Do not exceed the recommended dose.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use

Clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac functions, and of concomitant disease or other drug therapy.

TRINATAL ULTRA ADVERSE REACTIONS

Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

TRINATAL ULTRA DOSAGE AND ADMINISTRATION

Usual dosage is one (1) tablet daily or as prescribed by a physician.

HOW SUPPLIED

Trinatal Ultra is supplied in bottles of 100 tablets.

PRODUCT CODE 13811-615-10

STORAGE

Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F) [See USP controlled room temperature]. Protect from moisture and excessive heat. Note that contact with moisture may produce surface discoloration of the tablet.

Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).

KEEP OUT OF REACH OF CHILDREN

Rx Only

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. There are no implied or explicit claims on therapeutic equivalence.

Manufactured for:
TRIGEN Laboratories, Inc., Sayreville, NJ 08872
www.trigenlab.com

Rev. 05/13

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label

13811-615-10
Rx Only

Trinatal Ultra
Tablets

100 Tablets

TRIGEN
LABORATORIES

Trinatal Ultra

Trinatal Ultra

Vitamin A palmitate, .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine Hydrochloride, folic acid, cyanocobalamin, calcium citrate, iron pentacarbonyl, potassium iodide, zinc oxide, cupric oxide, and docusate sodium TABLET

Product Information

Product Type Dietary supplement Item Code (Source) NDC:13811-615
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
VITAMIN A PALMITATE 1350 [iU]
.BETA.-CAROTENE .BETA.-CAROTENE 1350 [iU]
ASCORBIC ACID ASCORBIC ACID 120 mg
CHOLECALCIFEROL CHOLECALCIFEROL 400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL- .ALPHA.-TOCOPHEROL, DL- 30 [iU]
THIAMINE MONONITRATE THIAMINE ION 3 mg
RIBOFLAVIN RIBOFLAVIN 3.4 mg
NIACINAMIDE 20 mg
PYRIDOXINE HYDROCHLORIDE PYRIDOXINE 20 mg
FOLIC ACID FOLIC ACID 1 mg
Cyanocobalamin CYANOCOBALAMIN 12 ug
CALCIUM CITRATE CALCIUM CATION 200 mg
IRON PENTACARBONYL FERROUS CATION 90 mg
Potassium Iodide IODIDE ION 150 ug
Zinc Oxide Zinc oxide 25 mg
CUPRIC OXIDE CUPRIC CATION 2 mg
DOCUSATE SODIUM DOCUSATE 50 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
Potassium Citrate Anhydrous
POVIDONE K30
ACACIA
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
CITRIC ACID MONOHYDRATE
STEARIC ACID
HYPROMELLOSES
titanium dioxide
POLYVINYL ALCOHOL
POLYETHYLENE GLYCOLS
talc

Product Characteristics

Color Size Imprint Code Shape
WHITE 22 mm TL615 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13811-615-10 100 in 1 BOTTLE, PLASTIC

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2011-05-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.